4D pharma (LBPS) Short Interest Ratio & Short Volume

Short interest is the volume of 4D pharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 58,600 shares of LBPS short. Learn More on 4D pharma's current short interest.

4D pharma saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 58,600 shares, a drop of 2.8% from the previous total of 60,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to 4D pharma: Context Therapeutics Inc. (0.08%), Grifols, S.A. (2.32%), LAVA Therapeutics (1.50%), Mainz Biomed (2.34%), NLS Pharmaceutics Ltd. (1.54%), Pharvaris (0.10%), Procaps Group S.A. (0.03%), Qilian International Holding Group Limited (0.07%), American Oncology Network, Inc. (1.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.58 billion), Occidental Petroleum Co. ($3.23 billion), Lucid Group, Inc. ($2.31 billion), Coinbase Global, Inc. ($1.73 billion), Snowflake Inc. ($1.71 billion), Chesapeake Energy Co. ($1.66 billion), Rivian Automotive, Inc. ($1.63 billion), Williams-Sonoma, Inc. ($1.51 billion), Lumen Technologies, Inc. ($1.40 billion), and Diamondback Energy, Inc. ($1.37 billion). View all of the most shorted stocks.

Short selling LBPS is an investing strategy that aims to generate trading profit from 4D pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for 4D pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LBPS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LBPS, twice per month. The most recent reporting period available is June, 15 2022.